 Geneva, Switzerland, November 3 , 2022 - Addex Therapeutics SIX and Nasdaq: ADXN, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it will issue its third quarter 2022 financial results on Friday, November 11, 2022 and provide a business update and review its pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CET 15:00 GMT 11:00 EDT 08:00 PDT the same day. 